Subcutaneous administration of alemtuzumab in patients with highly active multiple sclerosis. Perumal JS, Foo F, Cook P, Khan O Mult Scler. 2012 Aug; 18(8):1197-9. Epub 2012 Jan 17. PMID: 22252465. Abstract CommentRecommendBookmarkWatch
